HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead
- PMID: 37736874
- DOI: 10.2217/pme-2022-0074
HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead
Keywords: cancer; cost; cost effectiveness; diabetes; health economics; health outcome; histology-independent; pharmacogenomics; quality adjusted life year; tumor-agnostic.